Sign in or create an account to add this stock to your watchlist.
About Cardlytics (NASDAQ:CDLX)
Cardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. It also provides solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded in 2008 and is headquartered in Atlanta, Georgia.
Industry, Sector and Symbol
Industry Computer programming, data processing, & other computer related
Sub-IndustryN/A
SectorBusiness Services
SymbolNASDAQ:CDLX
CUSIPN/A
Phone888-798-5802
Debt
Debt-to-Equity Ratio0.81
Current Ratio1.68
Quick Ratio1.68
Price-To-Earnings
Trailing P/E Ratio-2.50
Forward P/E Ratio-10.16
P/E GrowthN/A
Sales & Book Value
Annual Sales$130.37 million
Price / Sales3.11
Cash FlowN/A
Price / CashN/A
Book Value$2.00 per share
Price / Book10.01
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees342
Outstanding Shares20,260,000
Cardlytics (NASDAQ:CDLX) Frequently Asked Questions
What is Cardlytics' stock symbol?
Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."
How were Cardlytics' earnings last quarter?
Cardlytics (NASDAQ:CDLX) released its quarterly earnings results on Monday, March, 19th. The company reported ($1.10) earnings per share for the quarter, beating the consensus estimate of ($1.35) by $0.25. The firm had revenue of $39.27 million for the quarter, compared to analysts' expectations of $38.48 million. View Cardlytics' Earnings History.
What price target have analysts set for CDLX?
6 equities research analysts have issued 12-month price targets for Cardlytics' shares. Their forecasts range from $19.00 to $25.00. On average, they anticipate Cardlytics' share price to reach $22.40 in the next twelve months. View Analyst Ratings for Cardlytics.
Are investors shorting Cardlytics?
Cardlytics saw a increase in short interest in the month of April. As of April 30th, there was short interest totalling 861,027 shares, an increase of 40.0% from the April 13th total of 614,820 shares. Based on an average trading volume of 94,969 shares, the short-interest ratio is presently 9.1 days. Approximately 10.2% of the shares of the stock are sold short.
Who are some of Cardlytics' key competitors?
Some companies that are related to Cardlytics include TrueCar (TRUE), Jianpu Technology (JT), Internet Initiative Japan (IIJI), 21Vianet Group (VNET), HealthStream (HSTM), Model N (MODN), Internap (INAP), Rubicon Project (RUBI), Edgewater Technology (EDGW), Synacor (SYNC), Sify Technologies (SIFY), AutoWeb (AUTO), ChinaNet Online (CNET), MassRoots (MSRT) and GigaMedia (GIGM).
Who are Cardlytics' key executives?
Cardlytics' management team includes the folowing people:
- Mr. Scott D. Grimes, Co-Founder, CEO & Director (Age 55)
- Ms. Lynne Marie Laube, Co-Founder, COO & Director (Age 49)
- Mr. David Evans, CFO & Head of Corp. Devel.
- Mr. Sathish Gaddipati, Chief Technology Officer (Age 51)
- Mr. Kirk L. Somers, Chief Legal & Privacy Officer (Age 53)
When did Cardlytics IPO?
(CDLX) raised $76 million in an IPO on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.
Has Cardlytics been receiving favorable news coverage?
Media coverage about CDLX stock has trended somewhat positive recently, Accern reports. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cardlytics earned a coverage optimism score of 0.16 on Accern's scale. They also gave news headlines about the company an impact score of 45.66 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future.
Who are Cardlytics' major shareholders?
Cardlytics' stock is owned by a number of of retail and institutional investors. Top institutional investors include Polaris Venture Management Co. V L.L.C. (13.18%), Federated Investors Inc. PA (2.00%), BlackRock Inc. (1.17%), Millennium Management LLC (0.87%), Citadel Advisors LLC (0.53%) and Kornitzer Capital Management Inc. KS (0.31%). Company insiders that own Cardlytics stock include David Thomas Evans and Scott D Grimes. View Institutional Ownership Trends for Cardlytics.
Which major investors are buying Cardlytics stock?
CDLX stock was bought by a variety of institutional investors in the last quarter, including Polaris Venture Management Co. V L.L.C., Federated Investors Inc. PA, BlackRock Inc., Millennium Management LLC, Citadel Advisors LLC, Kornitzer Capital Management Inc. KS, Northern Trust Corp and Penn Capital Management Co. Inc.. Company insiders that have bought Cardlytics stock in the last two years include David Thomas Evans and Scott D Grimes. View Insider Buying and Selling for Cardlytics.
How do I buy shares of Cardlytics?
Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cardlytics' stock price today?
One share of CDLX stock can currently be purchased for approximately $20.02.
How big of a company is Cardlytics?
Cardlytics has a market capitalization of $402.65 million and generates $130.37 million in revenue each year. The company earns $-19,640,000.00 in net income (profit) each year or ($8.02) on an earnings per share basis. Cardlytics employs 342 workers across the globe.
How can I contact Cardlytics?
Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected]
MarketBeat Community Rating for Cardlytics (CDLX)
MarketBeat's community ratings are surveys of what our community members think about Cardlytics and other stocks. Vote "Outperform" if you believe CDLX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CDLX will underperform the S&P 500 over the long term. You may vote once every thirty days.
Cardlytics (NASDAQ:CDLX) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
6 Wall Street analysts have issued ratings and price targets for Cardlytics in the last 12 months. Their average twelve-month price target is $22.40, suggesting that the stock has a possible upside of 11.89%. The high price target for CDLX is $25.00 and the low price target for CDLX is $19.00. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | N/A | N/A |
| Consensus Rating Score: | 2.83 | 2.83 | N/A | N/A |
| Ratings Breakdown: | 0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $22.40 | $22.40 | N/A | N/A |
| Price Target Upside: | 11.89% upside | 64.71% upside | N/A | N/A |
Cardlytics (NASDAQ:CDLX) Consensus Price Target History
Cardlytics (NASDAQ:CDLX) Analyst Ratings History
Show:
(Data available from 5/26/2016 forward)
Cardlytics (NASDAQ:CDLX) Earnings History and Estimates Chart
Cardlytics (NASDAQ:CDLX) Earnings Estimates
2018 EPS Consensus Estimate: ($1.86)
2019 EPS Consensus Estimate: ($0.76)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2018 | 2 | ($0.66) | ($0.57) | ($0.62) |
| Q2 2018 | 2 | ($0.44) | ($0.41) | ($0.43) |
| Q3 2018 | 2 | ($0.57) | ($0.53) | ($0.55) |
| Q4 2018 | 2 | ($0.33) | ($0.21) | ($0.27) |
| Q1 2019 | 1 | ($0.41) | ($0.41) | ($0.41) |
| Q2 2019 | 1 | ($0.20) | ($0.20) | ($0.20) |
| Q3 2019 | 1 | ($0.17) | ($0.17) | ($0.17) |
| Q4 2019 | 1 | $0.02 | $0.02 | $0.02 |
Cardlytics (NASDAQ CDLX) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 3/19/2018 | Q4 2017 | ($1.35) | ($1.10) | $38.48 million | $39.27 million | View | N/A |  |
(Earnings results data provided by Zacks Investment Research)
Cardlytics (NASDAQ:CDLX) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Cardlytics (NASDAQ CDLX) Insider Trading and Institutional Ownership History
Institutional Ownership Percentage: 48.32%
Cardlytics (NASDAQ CDLX) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/13/2018 | David Thomas Evans | CFO | Buy | 1,500 | $13.00 | $19,500.00 | | |
| 2/13/2018 | Scott D Grimes | CEO | Buy | 2,600 | $13.00 | $33,800.00 | | |
(Data available from 1/1/2013 forward)
Cardlytics (NASDAQ CDLX) News Headlines
| Source: |
|
Cardlytics (NASDAQ:CDLX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Cardlytics (NASDAQ CDLX) Stock Chart for Saturday, May, 26, 2018
Loading chart…
